PHT-1
PT
Menu
Search

Sections

  • Home
  • News
  • Analysis
    • Features
    • Comment
    • Data Insights
    • Projects
  • Sectors
    • Clinical Trials
    • Drug Manufacturers
    • Therapy Area
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Disease
      • Oncology
      • Respiratory
  • Themes
    • Artificial Intelligence
    • Corporate Governance
    • Cloud
    • Cybersecurity
    • Environmental Sustainability
    • Internet of Things
    • Robotics
    • Social Responsibility
    • Covid-19
  • Insights
    • Deals
    • Jobs
    • Filings
    • Patents
    • Social Media
  • Companies
    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos
    • Buyer’s Guides
    • Partner Content
  • Pricing and Market Access
  • Events
  • Reports
  • Awards & Rankings
  • Magazine

GlobalData

  • About us
  • Advertise With Us
  • Contact Us
  • Our Marketing Solutions
  • GlobalData Reports
  • Visit GlobalData

From Our Partners

  • Precision medicine and digital health innovation for disease diagnosis, care and treatment
  • Enabling process intensification in biopharma manufacturing
  • Specialty drug launch strategy and operations
  • The next chapter of clinical trial services
  • Powder Handling
  • Future Pharma Services
  • Putting quality first in the pharma supply chain
  • Accelerating Biopharmaceutical Innovation
  • Accelerating global access to medicines
  • Enabling better biopharmaceutical manufacturing
  • Pharmaceutical Grade Silicone Manufacturer
  • Maximising molecule potential
  • News
  • Analysis

    Sections

    • Features
    • Comment
    • Data Insights
    • Projects

    Latest

    • Price point is a key factor for wider market adoption of Amgen’s Amjevita in the US
    • HIV vaccines suffer setbacks but new approaches could turn the tide
    • Magazine: CRISPR gene therapies cut through in 2023
  • Sectors

    Sections

    • Clinical Trials
    • Drug Manufacturers
    • Therapy Area

    Latest

    • US FDA approves Amgen-AstraZeneca’s Tezspire for asthma treatment
    • MD Anderson partners with Federation Bio to develop microbiome therapy
    • Cidara Therapeutics expands partnership with WuXi XDC
  • Themes

    Sections

    • Artificial Intelligence
    • Cloud
    • Corporate Governance
    • Cybersecurity
    • Environmental Sustainability
    • Internet of Things
    • Robotics
    • Social Responsibility
    • Covid-19

    Latest

    • Pfizer’s Synthesis Facility, Ringaskiddy, Ireland
    • China’s NMPA conditionally approves two oral drugs for Covid-19
    • Health Canada accepts Veru’s Covid-19 therapy NDS-CV for review
  • Insights

    Sections

    • Deals
    • Jobs
    • Filings
    • Patents
    • Social Media

    Latest

    • Merck reports 2% increase in worldwide sales in Q4 2022
    • Pfizer reports 30% operational growth in full-year 2022 revenues
    • Who’s hiring who? Hiring activity related to robotics increased by 11% in the pharmaceutical industry in Q3 2022
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos
    • Buyer’s Guides
    • Partner Content

    Latest

    • Modernizing cell culture processes for the next wave of genomic medicine
    • Mitigating the risks of cross-contamination during Oral Solid Dose (OSD) manufacturing
    • How gas filter classification standards help users make the right selection
  • Events
  • Reports
PT
  • Companies
Left
Right
  • Company A-Z
  • Company Categories
  • Products & Services
  • Company Releases
  • White Papers
  • Videos
  • Buyer’s Guides
  • Partner Content

SMi Group

Subscribed

You have successfully subscribed and will receive the next available issues

Company white papers

Antimicrobial resistance has sparked an urgency in the development of new drugs as the industry strives for novel solutions to fight infectious diseases.

  • About us
  • White Papers

White Papers

CARB-X Chief Strategy Officer John Rex to Open Superbugs USA Summit

Antimicrobial resistance has sparked an urgency in the development of new drugs as the industry strives for novel solutions to fight infectious diseases.

PharmaceuticalTechnology

The leading site for news and procurement in the pharmaceutical industry

  • About us
  • Advertise with us
  • Contact us
  • Editorial approach
  • Newsletters
  • Our marketing solutions
  • Privacy policy
  • Terms and conditions

Powered by Pharma Tech Logo

© Verdict Media Limited 2023

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.